A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just ...

The 2025 Elaine and Michael Davies Award for Innovation will support earlier detection of osteoporosis and faster, more efficient treatment for a specific type of brain bleed for patients at Kingston ...

The Medal of Honor is presented to individuals whose research has fundamentally advanced cancer prevention, diagnosis, ...

An estimated 10 million Americans are living with osteoporosis, and another 44 million have low bone density, putting them at ...

Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, ...

Health officials are investigating an outbreak of E. coli in multiple states, including Florida, that appears to be linked to ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong ...

The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...

After the leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn ...

A new paper published in Osteoporosis International describes the rigorous, user-centered development of "Build Better Bones, ...

Q. I take pramipexole to treat restless leg syndrome. When I play casinos, I seem not to be able to stop playing. I have ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.